RLD & Comparator Drug Sourcing

PNV Lifesciences RLD & Comparator Drug Sourcing

RLD & Comparator Drug Sourcing

Enhance the efficiency of your clinical trials and generic drug development through strategic sourcing and Global distribution

There is massive global demand for generic drug alternatives. To take advantage of this, PNV Lifesciences helps you procure Reference Listed Drugs (RLDs) for your in-vivo bioequivalance studies.

We specialise in sourcing Innovator Samples/Reference Listed Drugs (RLDs) from USA, Canada, Brazil, Mexico, Europe, UK, Japan, Australia & Singapore through our extensive supplier network which allows us to procure and supply products from all major pharmaceutical manufacturers and distribution channels.

A combination of in-depth Knowledge of generic and branded products, coupled with strong relations with providers, enables us to facilitate the most appropriate information on clients requirements.

Securing a reliable source and planning for continuity is critical. Whether direct from manufacturer or from our robust network of suppliers, PNV Lifesciences provides you with the longest expiry available, sequential lots, documentation and contingency plans. These measures ensure quantity and quality over time and across distances. Your business outcomes are important for us.

We have partnered with leading logistics and courier partners which allow us to efficiently get your RLDs to you on or ahead of time. We provide an extensive range of services that ensure timely availability for clinical studies

  • Sourcing from a specific country
  • One to many pack delivery
  • In single or multi-batch lots
  • Long expiry dates
  • Specific batch number

Making Sure You Have The Desired Global Reach

How Customers Benefit

Customer Centricity
is the bedrock of our business
Consistency
Consistent supply
Compliance
Full product traceability/ Pedigree
Confidentiality
Client and supplier
Complete Logistics management
Efficient transportation
Challenging products
We have access to products that are difficult to source